News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Royal DSM Expands Its Biomedical Business With The Launch Of Its Cellular Therapy Development Services



8/13/2014 8:14:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in materials science and regenerative medicine, announced today the launch of its cellular therapy development services. Cellular therapies use a patient’s own cells to improve healing of an injury or disease. DSM develops products that are distributed by major biotechnology and medical device companies into the hands of qualified physicians, who are ultimately responsible for patient care. DSM’s expertise lies in the isolation and concentration of autologous cells at the point of care, along with the technologies to deliver these cells independently or in concert with a variety of other biomaterials to enhance therapeutic effect. DSM offers a complete package of design, development and manufacturing services to create cellular therapy products that are clinically valuable and commercially viable.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Royal DSM
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES